Valticetine hydrobromide is considered to be a novel multi-model antidepressant drug. In vitro studies have shown that it can antagonize 5-HT3, 5-HT7 and 5-HT1D receptors, activate 5-HT1A receptors, and partially activate 5- HT1B receptors and inhibit 5-HT transport.
For the treatment of mild to moderate or severe depression Neurogenic and Reactive Depression Physiotherapy, especially gastrointestinal distress Depression Anxiety Depression in patients with alcohol dependence during withdrawal.
White to slightly beige crystalline powder
White crystalline powder
1) Infrared absorption spectrum corresponds to the spectrum obtained with Vortioxetine Hydrobromide RS.
2) The retention time of the major peak in the chromatogram of the Sample solution corresponds to that in the chromatogram of the Standard solution, as obtained in the Assay.
3) It gives reactions to bromides
Related substances (HPLC)
Any unspecified impurity≤0.10%
98.0%~102.0%(Calculated on anhydrous and solvent-free basis)